RT Journal Article
SR Electronic
T1 750 A phase 1 trial of CUE-102, a novel WT1-pHLA-IL2-Fc fusion protein in HLA-A*0201 positive patients with WT1-positive recurrent/metastatic cancers
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A846
OP A846
DO 10.1136/jitc-2023-SITC2023.0750
VO 11
IS Suppl 1
A1 Eva Selfridge, J
A1 Uboha, Nataliya
A1 Saenger, Yvonne
A1 Chaves, Jorge
A1 Zheng, Lei
A1 Powderly, John
A1 Kim, Dae Won
A1 Alese, Olatunji
A1 Fu, Siqing
A1 Gong, Jun
A1 Gabrail, Nashat
A1 Zhaohui, Jin
A1 Bekaii-Saab, Tanios
A1 Alistar, Angela
A1 Agensky, Laura
A1 Goel, Apollina
A1 Margossian, Steven
A1 Quayle, Steve
A1 Levisetti, Matteo
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A846.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.